Neutrophil gelatinase-associated lipocalin: A novel inflammatory marker associated with late-life depression

Journal of Psychosomatic Research

Volumn 75, Issue 5, 2013, Pages 444-450

  Naude P J W ^a,b   Eisel, U L M ^a   Comijs, H C ^c   Groenewold, N A ^b   De Deyn, P P ^b,d   Bosker, F J ^b   Luiten, P G M ^a,b   den Boer, J A ^b   Oude Voshaar, R C ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Aging; Inflammation; Late life depression; Lipocalin 2; NESDO

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

AGED; AGING; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DEPRESSION; DSM-IV-TR; DYSTHYMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; LATE LIFE DEPRESSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; NEUTROPHIL; PLASMA; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT;

AGING; INFLAMMATION; LATE-LIFE DEPRESSION; LIPOCALIN 2; NESDO;

ACUTE-PHASE PROTEINS; AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERVIEW, PSYCHOLOGICAL; LIFE STYLE; LIPOCALINS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RECURRENCE;

EID: 84886948504     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.08.023     Document Type: Article

References (45)

1. Smith RS The macrophage theory of depression. Med Hypotheses 1991, 35:298-306.
2. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiat 2010, 67:446-457.
3. Howren MB, Lamkin DM, Suls J Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
4. Krishnadas R., Cavanagh J. Depression: an inflammatory illness?. J Neurol Neurosurg Psychiatry 2012, 83:495-502.
5. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199-226.
6. Vogelzangs N, Duivis HE, Beekman AT, Kluft C, Neuteboom J, Hoogendijk W, et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2012, 2:e79.
7. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiat Res 2011, 46:57-63.
8. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatr 2011, 16:751-762.
9. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
10. Naudé PJW, Nyakas C, Eiden LE, Ait-Ali D, Rvd Heide, Engelborghs S, et al. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J 2012, 26:2811-2823.
11. Ip JP, Nocon AL, Hofer MJ, Lim SL, Muller M, Campbell IL Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J Neuroinflammation 2011, 8:124.
12. Mucha M, Skrzypiec AE, Schiavon E, Attwood BK, Kucerova E, Pawlak R Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc Natl Acad Sci U S A 2011, 108:18436-18441.
13. Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, et al. Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus 2012, 22:230-240.
14. Jin Y, Sui HJ, Dong Y, Ding Q, Qu WH, Yu SX, et al. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3beta signaling pathways. Acta Pharmacol Sin 2012, 33:861-872.
15. Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R, et al. Alterations in phosphatidylinositol 3-kinase activity and PTEN phosphatase in the prefrontal cortex of depressed suicide victims. Neuropsychobiology 2011, 63:224-231.
16. Duman RS, Monteggia LM A neurotrophic model for stress-related mood disorders. Biol Psychiatr 2006, 59:1116-1127.
17. Duman R Role of neurotrophic factors in the etiology and treatment of mood disorders. Neruomol. Med. 2004, 5:11-25.
18. Lim HK, Jung WS, Ahn KJ, Won WY, Hahn C, Lee SY, et al. Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression. Neuropsychopharmacol 2012, 37:838-849.
19. Comijs HC, Van Marwijk HW, Van Der Mast RC, Naarding P, Oude Voshaar RC, Beekman AT, et al. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res Notes 2011, 4:524.
20. World Health O Composite International Diagnostic Interview. Version 2.1 1997, WHO, Geneva.
21. Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med Engl 2010, 225-237.
22. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008, 17:121-140.
23. Babor TFH-B, Saunders John C, Monteiro John B, Maristela G AUDIT - the alcohol use disorders identification test: guidelines for use in primary care 2001, World Health Organisation, Geneva, Switzerland. 2nd ed.
24. Aalto M, Alho H, Halme JT, Seppa K The alcohol use disorders identification test (AUDIT) and its derivatives in screening for heavy drinking among the elderly. Int J Geriatr Psychiatry 2011, 26:881-885.
25. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
26. Folstein M, Folstein S, McHugh P "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
27. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996, 49:1407-1417.
28. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology [Accessed January 2012]. http://www.whocc.no/atc_ddd_index/.
29. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-486.
30. Beck AT, Epstein N, Brown G, Steer RA An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psych 1988, 56:893-897.
31. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrino 2011, 36:228-239.
32. Bus BA, Tendolkar I, Franke B, de Graaf J, Heijer MD, Buitelaar JK, et al. Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry 2012, 13:39-47.
33. Franceschi C, Valensin S, Bonafè M, Paolisso G, Yashin AI, Monti D, et al. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000, 35:879-896.
34. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
35. Singh T, Newman AB Inflammatory markers in population studies of aging. Ageing Res Rev 2011, 10:319-329.
36. Blazer DG, Hybels CF, Pieper CF The association of depression and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2001, 56:M505-M509.
37. Bolignano D, Coppolino G, Lacquaniti A, Buemi M From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest 2010, 40:273-276.
38. Choi J, Lee H-W, Suk K Increased plasma levels of lipocalin 2 in mild cognitive impairment. J Neurol Sci 2011, 305:28-33.
39. Raison CL, Capuron L, Miller AH Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
40. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009, 39:413-423.
41. Forti P, Rietti E, Pisacane N, Olivelli V, Mariani E, Chiappelli M, et al. Blood inflammatory proteins and risk of incident depression in the elderly. Dement Geriatr Cogn Disord 2010, 29:11-20.
42. Hannestad J, DellaGioia N, Bloch M The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacol 2011, 36:2452-2459.
43. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacol 1999, 20:370-379.
44. Pedersen KR, Ravn HB, Hjortdal VE, Norregaard R, Povlsen JV Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA. Scand J Clin Lab Invest 2010, 70:374-382.
45. Soni S, Cruz D, Bobek I, Chionh C, Nalesso F, Lentini P, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010, 42:141-150.